Chen Schor - May 19, 2021 Form 4 Insider Report for Adicet Bio, Inc. (ACET)

Role
President & CEO, Director
Signature
/s/ Nick Harvey, Attorney-in-Fact
Stock symbol
ACET
Transactions as of
May 19, 2021
Transactions value $
-$221,436
Form type
4
Date filed
5/21/2021, 04:34 PM
Previous filing
May 7, 2021
Next filing
May 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACET Common Stock Sale -$92.2K -6.87K -7.06% $13.42 90.4K May 19, 2021 See Footnote F1, F2, F3
transaction ACET Common Stock Sale -$8.4K -612 -0.68% $13.73 89.8K May 19, 2021 See Footnote F1, F3, F4
transaction ACET Common Stock Sale -$111K -8.25K -7.06% $13.42 109K May 19, 2021 See Footnote F1, F2, F5
transaction ACET Common Stock Sale -$10.1K -733 -0.68% $13.73 108K May 19, 2021 See Footnote F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $12.69 to $13.66, inclusive.
F3 Represents shares held directly by an irrevocable family trust having an independent trustee.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $13.69 to $13.79, inclusive.
F5 Represents shares held directly by an irrevocable family trust having an independent trustee.